To test if NME4 performs its function as a key regulator of NAFLD by binding to these key enzymes, we constructed a mito-deletion plasmid of NME4, which can no longer localize to mitochondria (Fig. 7A). This evidence concerns the gene NME4 and metabolic dysfunction-associated steatotic liver disease.